Screened 2026-09-16 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
Evolv Technologies Holdings, Inc. holds its Markdown at $5.05. The statistical read favours the sellers, held for 271 days.
As held on the ledger · 2026-09-16
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 271 days
Price at the screen
$5.05
Valuation
N/A trailing · -137.58 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.80
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
13.88%
Below 33%
Interest-bearing debt is just 13.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
6.53%
Below 33%
Cash held in interest-bearing accounts and securities is 6.5% of assets, under the one-third limit.
Pass
Receivables
26.28%
Below 49%
Money owed to the company is 26.3% of assets, under the 49% limit.
Pass
Revenue purity
1.05%
Below 5%
Only 1.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. A 98.2% margin of safety to the base estimate.
Third-party analyst targets: 5 covering, consensus Strong Buy. The average target sits +98% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Airport scanners racing ahead but still losing cash
Picture the line at a big event or transport hub where every bag and body needs checking without the old delays. Evolv builds machines that spot guns and bombs faster than traditional metal detectors, and revenue is rising 45 percent a year as more venues sign up. Yet the business still posts a 23 percent negative profit margin and a negative 30 percent return on equity, so the growth has not turned into real earnings.
The market gives the shares a strong buy rating and a ten dollar target that sits well above the current price, implying plenty of future expansion. That view rests on the idea that security demand will keep climbing and margins will follow. Our screen clears the ethical test, but the numbers show a company that has yet to prove it can convert sales into sustainable profit.
Risks sit around the heavy losses and negative forward earnings multiple that leave little room for any slip in execution or slower orders. Without a clear moat the edge could erode if bigger rivals copy the approach. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
EVLV trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-28Markdown · changed$5.32-6.0%Entry 5
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it strong buy, with a mean price target of $10.
2026-07-28Distribution$5.66-7.1%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it strong buy, with a mean price target of $10.
2026-07-18Distribution$6.09+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it strong buy, with a mean price target of $10.
2026-07-03Distribution$6.09+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Distribution$6.09Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.